Report Type

Single Stock Report Research Hub

Finvaulta tracks 1002 research reports on Single Stock Report, updated through September 3, 2026. Latest: “F3Q Preview: The Picture Is Still Rendering”.

Recent single-stock research reports highlight how secular technology drivers, proprietary product innovations, and disciplined capital allocation are driving notable earnings estimate revisions and target price adjustments across global equities. Generative AI adoption serves as a powerful revenue accelerator, evidenced by Snowflake's raised FY27 product revenue guidance and margin outperformance driven by enterprise tools like CoCo, as well as surging demand for RoboTechnik's photonics IC testing equipment. In the medical technology sector, defensible competitive moats underpin high-conviction upgrades, such as Medartis's multi-year regulatory head start with its FDA-approved KeriTOUCH prosthesis supporting a projected 61% EPS CAGR through 2030. In contrast, analysts maintain more measured Neutral stances on established industrial and distribution leaders like SMC and Bunzl, where solid operational beats and semiconductor momentum are balanced against margin normalization trajectories and a desire for enhanced shareholder returns. Across coverage, proactive capital deployment remains pivotal for equity support, illustrated by Bunzl's £500 million share buyback bolstering mid-term EPS expectations. Overall, analysts are rewarding businesses demonstrating tangible AI-driven growth acceleration and proprietary product advantages while closely scrutinizing normalized margin sustainability.

Featured reports

F3Q Preview: The Picture Is Still Rendering thumbnail

F3Q Preview: The Picture Is Still Rendering

Deutsche Bank·Sep 3, 2026

Deutsche Bank previews Adobe's F3Q results, reiterating a Hold rating and a $260 price target. While conservative guidance and the Semrush acquisition could enable modest top-line upside, wider FY27 ARR growth dispersion and the ongoing CEO search keep near-term share outperformance constrained.

Snowflake Inc.: AI-Driven Inflections Support Structurally Higher Medium-Term Growth thumbnail

Snowflake Inc.: AI-Driven Inflections Support Structurally Higher Medium-Term Growth

Goldman Sachs·Sep 3, 2026

Goldman Sachs reiterates a Buy rating on Snowflake and raises its price target to $436 from $300 following strong 2QFY results and an upward guidance revision. Revenue acceleration is being propelled by both emerging AI solutions like Cortex Code and faster enterprise migrations to the core platform.

Bunzl: 1H'26 Solid Results; Focus Shifts to Normalizing Margin Potential in 2H thumbnail

Bunzl: 1H'26 Solid Results; Focus Shifts to Normalizing Margin Potential in 2H

Goldman Sachs·Sep 3, 2026

Goldman Sachs maintains a Neutral rating on Bunzl, nudging its price target up to 3,000p from 2,920p following solid 1H'26 results and a £500m buyback announcement. While 2H margins should remain resilient, margins are expected to normalize to 7.7% in 2027 as inflation tailwinds subside.

F2Q - Revving Up the Flywheel thumbnail

F2Q - Revving Up the Flywheel

Deutsche Bank·Sep 3, 2026

Snowflake reported strong F2Q results with Product revenue accelerating 36.8% y/y to $1,492m and Non-GAAP operating margin jumping to 15.3%. Deutsche Bank maintained its Buy rating and lifted its price target to $400 from $350 on accelerating AI adoption and durable consumption trends.

Interroll: E-Commerce Is Investing Again and Driving Earnings Growth thumbnail

Interroll: E-Commerce Is Investing Again and Driving Earnings Growth

Zürcher Kantonalbank·Aug 28, 2026

Zürcher Kantonalbank reiterates an Outperform rating on Interroll with a fair value of CHF 2,744 per share, anticipating an acceleration in revenue and profit growth in 2027 driven by a recovery in e-commerce and logistics automation investments.

BWXT Reactor Selected for U.S. Army's Janus Program thumbnail

BWXT Reactor Selected for U.S. Army's Janus Program

Northland Capital Markets·Aug 27, 2026

BWXT was selected alongside 4 other vendors to support the U.S. Army's Janus Program to deploy its BANR microreactor at Fort Campbell, Kentucky. Northland reiterates an Outperform rating with a $250 price target, noting positive validation and fuel supply upside.

Medartis: Rating Change to Outperform - Medartis Is Revolutionising the Market thumbnail

Medartis: Rating Change to Outperform - Medartis Is Revolutionising the Market

Zürcher Kantonalbank·Aug 26, 2026

Zürcher Kantonalbank upgrades Medartis from Market Perform to Outperform with a fair value of CHF 130 (40% upside). Growth is driven by the US launch of KeriTOUCH, the only FDA-approved dual-mobility CMC-1 thumb implant, which provides a 3–5 year competitive lead.

Bitcoin and MSTR: The Debasement Trade (Updated Target Prices) thumbnail

Bitcoin and MSTR: The Debasement Trade (Updated Target Prices)

Bernstein·Aug 26, 2026

Bernstein reiterates an Outperform rating on Strategy Inc (MSTR) with a revised price target of $350 (down from $450), rolling forward its valuation to June 2027. The thesis is anchored on the global currency debasement trade favoring Bitcoin, projected to reach $150K by mid-2027E and $300K by CY2029E.

Zscaler: Strong Finish and Improving Organic Momentum; FY27 Guide Keeps Bar Low

Bank of America·Sep 4, 2026

Porsche AG: Back to School Autos (Virtual) Fieldtrip Feedback

Bank of America·Sep 4, 2026

Oracle Corporation: 1Q27 Preview: Capacity Additions Could Support the Growth Reacceleration Story

Bank of America·Sep 4, 2026

Sign up to access 994 more reports

All reports

Page 1 of 42

Use in AI assistants

Search this research archive inside ChatGPT, Claude, or Perplexity.

ChatGPTClaudePerplexity

Related

Goldman SachsEquitiesZürcher KantonalbankIndustrialsEnergyNuclear Power

Get full access

Create an account to follow this research